Surgepays Cash And Cash Equivalents Changes vs Begin Period Cash Flow Analysis

SURG Stock

USD 1.92 0.19 9.00%

Surgepays financial indicator trend analysis is much more than just breaking down Surgepays prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Surgepays is a good investment. Please check the relationship between Surgepays Cash And Cash Equivalents Changes and its Begin Period Cash Flow accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Surgepays. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more detail on how to invest in Surgepays Stock please use our How to Invest in Surgepays guide.

Cash And Cash Equivalents Changes vs Begin Period Cash Flow

Cash And Cash Equivalents Changes vs Begin Period Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Surgepays Cash And Cash Equivalents Changes account and Begin Period Cash Flow. At this time, the significance of the direction appears to have pay attention.

The correlation between Surgepays' Cash And Cash Equivalents Changes and Begin Period Cash Flow is -0.78. Overlapping area represents the amount of variation of Cash And Cash Equivalents Changes that can explain the historical movement of Begin Period Cash Flow in the same time period over historical financial statements of Surgepays, assuming nothing else is changed. The correlation between historical values of Surgepays' Cash And Cash Equivalents Changes and Begin Period Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash And Cash Equivalents Changes of Surgepays are associated (or correlated) with its Begin Period Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Begin Period Cash Flow has no effect on the direction of Cash And Cash Equivalents Changes i.e., Surgepays' Cash And Cash Equivalents Changes and Begin Period Cash Flow go up and down completely randomly.

Correlation Coefficient

-0.78

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Cash And Cash Equivalents Changes

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Most indicators from Surgepays' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Surgepays current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Surgepays. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more detail on how to invest in Surgepays Stock please use our How to Invest in Surgepays guide.At this time, Surgepays' Enterprise Value Multiple is most likely to increase in the upcoming years. The Surgepays' current Enterprise Value is estimated to increase to about 86.9 M, while Issuance Of Capital Stock is projected to decrease to 516.75.

	2023	2024 (projected)
Interest Income	1.3M	1.1M
Reconciled Depreciation	1.1M	740.0K

Interest Income Reconciled Depreciation

Surgepays fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Cash	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Non Current Assets Total	Non Currrent Assets Other	Short Long Term Debt Total	Property Plant And Equipment Net	Current Deferred Revenue	Net Receivables	Short Term Debt	Long Term Debt	Intangible Assets	Property Plant Equipment
Total Assets		0.47	0.79	0.85	-0.64	-0.64	0.79	0.97	0.97	0.99	0.3	-0.02	0.96	0.63	0.99	0.14	0.89	0.39	0.58	0.87	-0.39	0.98	0.74	0.3	0.5	0.94
Other Current Liab	0.47		0.77	0.09	0.03	-0.65	0.49	0.27	0.27	0.5	0.42	-0.07	0.48	0.76	0.48	0.07	0.37	0.24	0.5	0.63	-0.01	0.55	0.27	0.44	0.34	0.42
Total Current Liabilities	0.79	0.77		0.37	-0.13	-0.86	0.91	0.64	0.64	0.77	0.54	0.01	0.79	0.93	0.75	0.06	0.83	0.48	0.82	0.92	-0.09	0.78	0.77	0.52	0.68	0.79
Total Stockholder Equity	0.85	0.09	0.37		-0.92	-0.21	0.41	0.94	0.94	0.87	-0.13	-0.18	0.78	0.14	0.88	0.09	0.61	0.2	0.12	0.51	-0.57	0.83	0.52	-0.12	0.1	0.7
Net Debt	-0.64	0.03	-0.13	-0.92		-0.01	-0.13	-0.79	-0.79	-0.69	0.45	0.47	-0.58	0.14	-0.71	-0.06	-0.29	-0.01	0.22	-0.23	0.66	-0.62	-0.31	0.43	0.25	-0.42
Retained Earnings	-0.64	-0.65	-0.86	-0.21	-0.01		-0.86	-0.51	-0.51	-0.57	-0.71	0.0	-0.78	-0.9	-0.6	-0.11	-0.7	-0.32	-0.85	-0.86	-0.05	-0.6	-0.53	-0.71	-0.69	-0.76
Accounts Payable	0.79	0.49	0.91	0.41	-0.13	-0.86		0.69	0.69	0.74	0.65	0.13	0.82	0.88	0.73	0.15	0.91	0.47	0.89	0.93	-0.12	0.75	0.78	0.61	0.78	0.88
Cash	0.97	0.27	0.64	0.94	-0.79	-0.51	0.69		1.0	0.96	0.12	-0.14	0.93	0.44	0.97	0.14	0.81	0.31	0.42	0.76	-0.48	0.93	0.7	0.12	0.36	0.88
Cash And Short Term Investments	0.97	0.27	0.64	0.94	-0.79	-0.51	0.69	1.0		0.96	0.12	-0.14	0.93	0.44	0.97	0.14	0.81	0.31	0.42	0.76	-0.48	0.93	0.7	0.12	0.36	0.88
Common Stock Shares Outstanding	0.99	0.5	0.77	0.87	-0.69	-0.57	0.74	0.96	0.96		0.21	-0.09	0.93	0.59	0.99	0.13	0.84	0.36	0.5	0.83	-0.44	0.98	0.73	0.2	0.42	0.89
Non Current Liabilities Total	0.3	0.42	0.54	-0.13	0.45	-0.71	0.65	0.12	0.12	0.21		0.65	0.37	0.77	0.23	0.2	0.54	0.24	0.86	0.63	0.31	0.32	0.17	0.99	0.8	0.57
Other Current Assets	-0.02	-0.07	0.01	-0.18	0.47	0.0	0.13	-0.14	-0.14	-0.09	0.65		-0.12	0.22	-0.1	0.09	0.26	0.09	0.44	0.14	0.32	0.04	-0.03	0.63	0.51	0.2
Other Stockholder Equity	0.96	0.48	0.79	0.78	-0.58	-0.78	0.82	0.93	0.93	0.93	0.37	-0.12		0.67	0.95	0.13	0.84	0.33	0.62	0.89	-0.33	0.92	0.68	0.38	0.51	0.94
Total Liab	0.63	0.76	0.93	0.14	0.14	-0.9	0.88	0.44	0.44	0.59	0.77	0.22	0.67		0.57	0.13	0.76	0.44	0.93	0.88	0.09	0.63	0.59	0.75	0.8	0.74
Total Current Assets	0.99	0.48	0.75	0.88	-0.71	-0.6	0.73	0.97	0.97	0.99	0.23	-0.1	0.95	0.57		0.11	0.82	0.35	0.5	0.83	-0.45	0.98	0.68	0.23	0.4	0.9
Common Stock	0.14	0.07	0.06	0.09	-0.06	-0.11	0.15	0.14	0.14	0.13	0.2	0.09	0.13	0.13	0.11		0.14	-0.26	0.14	0.22	0.13	0.09	-0.03	0.18	0.24	0.18
Non Current Assets Total	0.89	0.37	0.83	0.61	-0.29	-0.7	0.91	0.81	0.81	0.84	0.54	0.26	0.84	0.76	0.82	0.14		0.53	0.83	0.9	-0.12	0.85	0.86	0.51	0.8	0.94
Non Currrent Assets Other	0.39	0.24	0.48	0.2	-0.01	-0.32	0.47	0.31	0.31	0.36	0.24	0.09	0.33	0.44	0.35	-0.26	0.53		0.47	0.4	-0.21	0.37	0.5	0.26	0.4	0.39
Short Long Term Debt Total	0.58	0.5	0.82	0.12	0.22	-0.85	0.89	0.42	0.42	0.5	0.86	0.44	0.62	0.93	0.5	0.14	0.83	0.47		0.85	0.19	0.56	0.63	0.84	0.93	0.77
Property Plant And Equipment Net	0.87	0.63	0.92	0.51	-0.23	-0.86	0.93	0.76	0.76	0.83	0.63	0.14	0.89	0.88	0.83	0.22	0.9	0.4	0.85		-0.14	0.85	0.73	0.62	0.75	0.93
Current Deferred Revenue	-0.39	-0.01	-0.09	-0.57	0.66	-0.05	-0.12	-0.48	-0.48	-0.44	0.31	0.32	-0.33	0.09	-0.45	0.13	-0.12	-0.21	0.19	-0.14		-0.4	-0.17	0.36	0.43	-0.23
Net Receivables	0.98	0.55	0.78	0.83	-0.62	-0.6	0.75	0.93	0.93	0.98	0.32	0.04	0.92	0.63	0.98	0.09	0.85	0.37	0.56	0.85	-0.4		0.67	0.32	0.46	0.91
Short Term Debt	0.74	0.27	0.77	0.52	-0.31	-0.53	0.78	0.7	0.7	0.73	0.17	-0.03	0.68	0.59	0.68	-0.03	0.86	0.5	0.63	0.73	-0.17	0.67		0.13	0.59	0.69
Long Term Debt	0.3	0.44	0.52	-0.12	0.43	-0.71	0.61	0.12	0.12	0.2	0.99	0.63	0.38	0.75	0.23	0.18	0.51	0.26	0.84	0.62	0.36	0.32	0.13		0.79	0.57
Intangible Assets	0.5	0.34	0.68	0.1	0.25	-0.69	0.78	0.36	0.36	0.42	0.8	0.51	0.51	0.8	0.4	0.24	0.8	0.4	0.93	0.75	0.43	0.46	0.59	0.79		0.69
Property Plant Equipment	0.94	0.42	0.79	0.7	-0.42	-0.76	0.88	0.88	0.88	0.89	0.57	0.2	0.94	0.74	0.9	0.18	0.94	0.39	0.77	0.93	-0.23	0.91	0.69	0.57	0.69

Click cells to compare fundamentals

Surgepays Account Relationship Matchups

Surgepays fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	10.0M	7.3M	19.5M	34.0M	41.9M	44.0M
Other Current Liab	678.0K	1.9M	555.1K	12.9M	1.0M	1.4M
Total Current Liabilities	7.1M	15.3M	10.0M	23.5M	12.7M	13.3M
Total Stockholder Equity	(4.7M)	(10.7M)	3.6M	5.0M	28.2M	29.7M
Net Debt	8.2M	7.0M	1.4M	1.1M	(9.2M)	(8.7M)
Retained Earnings	(10.9M)	(21.6M)	(35.1M)	(35.8M)	(15.2M)	(14.4M)
Accounts Payable	4.6M	7.3M	7.4M	7.5M	6.4M	6.8M
Cash	346.0K	674.0K	6.3M	7.0M	14.6M	15.4M
Cash And Short Term Investments	346.0K	674.0K	6.3M	7.0M	14.6M	15.4M
Common Stock Shares Outstanding	1.9M	2.1M	4.4M	12.4M	14.9M	15.7M
Liabilities And Stockholders Equity	10.0M	7.3M	19.5M	34.0M	41.9M	44.0M
Non Current Liabilities Total	7.6M	2.7M	6.0M	5.4M	816.8K	776.0K
Other Current Assets	1.4M	172.6B	5.6K	111.5K	161.9K	153.8K
Other Stockholder Equity	6.1M	10.7M	38.7M	40.8M	43.4M	45.6M
Total Liab	14.7M	18.1M	15.9M	28.9M	13.5M	7.7M
Total Current Assets	3.6M	1.3M	13.9M	27.6M	33.4M	35.0M
Common Stock	102.2K	127.1K	12.1K	14.1K	14.4K	15.1K
Non Current Assets Total	6.4M	6.1M	5.6M	6.4M	8.6M	9.0M
Non Currrent Assets Other	61.5K	66.5K	61.5K	176.9K	203.4K	213.5K
Short Long Term Debt Total	8.5M	7.7M	7.7M	8.1M	5.4M	3.8M
Property Plant And Equipment Net	505.4K	605.4K	687.1K	1.1M	749.7K	787.2K
Net Receivables	3.1M	393.1K	3.2M	9.2M	9.5M	10.0M
Short Term Debt	1.7M	5.3M	1.7M	2.7M	4.7M	4.9M
Other Assets	(4K)	66.5K	61.5K	176.9K	203.4K	213.5K
Long Term Debt	6.6M	1.7M	5.5M	5.0M	460.5K	437.5K
Inventory	(172.6B)	178.3K	4.4M	11.2M	9.0M	9.5M
Intangible Assets	4.8M	4.1M	3.4M	3.2M	2.7M	2.0M
Property Plant Equipment	31.0K	505.4K	236.8K	687.1K	790.2K	829.7K
Net Tangible Assets	(2.9M)	(10.3M)	(15.7M)	(749.2K)	(674.3K)	(708.0K)
Short Long Term Debt	2.1M	5.9M	1.7M	2.7M	4.6M	2.5M
Other Liab	883.6K	600.5K	869.9K	852.0K	979.8K	808.9K
Net Invested Capital	4.0M	(3.1M)	10.7M	12.7M	33.3M	35.0M
Net Working Capital	(3.5M)	(14.1M)	3.9M	4.1M	20.7M	21.7M
Capital Stock	115.9K	140.9K	12.3K	14.1K	14.4K	13.7K

Currently Active Assets on Macroaxis

ESRT	Empire State Realty
C	Citigroup
C	Citigroup
GOOG	Alphabet Inc Class C
DD	Dupont De Nemours

When determining whether Surgepays is a strong investment it is important to analyze Surgepays' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Surgepays' future performance. For an informed investment choice regarding Surgepays Stock, refer to the following important reports:

How To Invest In Surgepays

Details

Is Surgepays Stock a good investment?

Details

What is Surgepays' Net Worth?

Details

Largest Wireless Telecommunication Services Companies

View

Largest Telecommunication Services Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Surgepays. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more detail on how to invest in Surgepays Stock please use our How to Invest in Surgepays guide.

You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Is Wireless Telecommunication Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Surgepays. If investors know Surgepays will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Surgepays listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.78)

Earnings Share

(1.18)

Revenue Per Share

6.864

Quarterly Revenue Growth

(0.58)

Return On Assets

(0.02)

The market value of Surgepays is measured differently than its book value, which is the value of Surgepays that is recorded on the company's balance sheet. Investors also form their own opinion of Surgepays' value that differs from its market value or its book value, called intrinsic value, which is Surgepays' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Surgepays' market value can be influenced by many factors that don't directly affect Surgepays' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Surgepays' value and its price as these two are different measures arrived at by different means. Investors typically determine if Surgepays is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Surgepays' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Surgepays Cash And Cash Equivalents Changes vs Begin Period Cash Flow Analysis

Cash And Cash Equivalents Changes vs Begin Period Cash Flow

Cash And Cash Equivalents Changes vs Begin Period Cash Flow Correlation Analysis

Correlation Coefficient

Cash And Cash Equivalents Changes

Begin Period Cash Flow

Surgepays fundamental ratios Correlations

Surgepays Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Surgepays fundamental ratios Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Common Stock Shares Outstanding	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Common Stock Shares Outstanding
Long Term Debt	+ 0.99	Non Current Liabilities Total
Net Receivables	+ 0.98	Total Assets

Net Debt	- 0.92	Total Stockholder Equity
Total Liab	- 0.9	Retained Earnings
Property Plant And Equipment Net	- 0.86	Retained Earnings
Accounts Payable	- 0.86	Retained Earnings
Retained Earnings	- 0.86	Total Current Liabilities
Short Long Term Debt Total	- 0.85	Retained Earnings